Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice

2012 ◽  
Vol 76 (5) ◽  
pp. 729-733 ◽  
Author(s):  
Niamh Phelan ◽  
Sophy H. Conway ◽  
Sofia Llahana ◽  
Gerard S. Conway
Author(s):  
Erum Rasheed ◽  
Sarah Savage ◽  
Elena Walsh ◽  
Nadia Brazil ◽  
Nicola Ralph ◽  
...  

We report a case of 33-year old female with underlying genetic susceptibility for familial porphyria cutanea tarda (PCT) due to novel UROD variant (c.636+2 dupT) unmasked by transient exposure to supraphysiological estrogen levels following a single cycle of successful controlled ovarian stimulation for oocyte retrieval. Use of oral estrogen in the form of oral contraceptive pills and hormone replacement therapy has been well known to trigger active PCT phenotype in susceptible women. However, to date the emergence of clinically overt PCT has not been reported in association with fertility treatment in the literature before. Keywords: Familial PCT, UROD mutation, Ovarian stimulation, Estrogen


2018 ◽  
Vol 2 (1) ◽  
Author(s):  
Sameerah Mustafa ◽  
Asal Tawfeeq ◽  
Hadeel Hasan

This study involved the collection of (90) samples of women serum which included (30) serum samples collected from women before menopause (reproductive women) in the age range of (22-43) years and were considered as (group A- control). While, (group B) included (30) serum samples collected from women using oral contraceptive pills between the ages of (22-43) years old. Whereas, another (30) serum samples were collected from women after menopause between the ages of (43-54) years and were considered as (group C). All of the collected serum samples were subjected to a number of serological and chemical tests for the measurement of (E2, HDL, LDL and Ca). Then, the obtained data were statistical analyzed and results showed a significant decrease (p˂ 0.05) in (E2 ,Ca and HDL) levels in menopausal women compared to that of the normal healthy controls. While, there were non-significant decrease (p> 0.05) in (E2, Ca and HDL) levels in women taking oral contraceptive when compared to the normal healthy controls. On the other hand, a significant increase (p˂ 0.05) was recorded in LDL level in menopausal women compared to that of the normal healthy controls whereas, no-significant increase (p˃ 0.05) in the LDL level in women taking oral contraceptives when compared to the control women.


Sign in / Sign up

Export Citation Format

Share Document